HUE048843T2 - Gombaölõ szer 4-(4-(4-(((3R,5R)-5-((1H -1,2,4-triazol-1-YL)metil)-5-(2,4-difluor-fenil)tetra-hidro-furán-3-YL)metoxi)-3 metilfenil)piperazin-1-il)-n -(2-hidroxi-ciklohexil)benzamid, vagy annak gyógyszerészetileg elfogadható sója - Google Patents
Gombaölõ szer 4-(4-(4-(((3R,5R)-5-((1H -1,2,4-triazol-1-YL)metil)-5-(2,4-difluor-fenil)tetra-hidro-furán-3-YL)metoxi)-3 metilfenil)piperazin-1-il)-n -(2-hidroxi-ciklohexil)benzamid, vagy annak gyógyszerészetileg elfogadható sójaInfo
- Publication number
- HUE048843T2 HUE048843T2 HUE16724958A HUE16724958A HUE048843T2 HU E048843 T2 HUE048843 T2 HU E048843T2 HU E16724958 A HUE16724958 A HU E16724958A HU E16724958 A HUE16724958 A HU E16724958A HU E048843 T2 HUE048843 T2 HU E048843T2
- Authority
- HU
- Hungary
- Prior art keywords
- hydroxycyclohexyl
- piperazin
- difluorophenyl
- triazol
- benzamide
- Prior art date
Links
- 230000000843 anti-fungal effect Effects 0.000 title 1
- 229940121375 antifungal agent Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15168637 | 2015-05-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE048843T2 true HUE048843T2 (hu) | 2020-08-28 |
Family
ID=53267232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16724958A HUE048843T2 (hu) | 2015-05-21 | 2016-05-20 | Gombaölõ szer 4-(4-(4-(((3R,5R)-5-((1H -1,2,4-triazol-1-YL)metil)-5-(2,4-difluor-fenil)tetra-hidro-furán-3-YL)metoxi)-3 metilfenil)piperazin-1-il)-n -(2-hidroxi-ciklohexil)benzamid, vagy annak gyógyszerészetileg elfogadható sója |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9969720B2 (enExample) |
| EP (1) | EP3298006B1 (enExample) |
| JP (1) | JP6811727B2 (enExample) |
| KR (1) | KR102653821B1 (enExample) |
| CN (1) | CN107635988B (enExample) |
| AU (1) | AU2016263669B2 (enExample) |
| CA (1) | CA2981945C (enExample) |
| DK (1) | DK3298006T3 (enExample) |
| EA (1) | EA032454B1 (enExample) |
| ES (1) | ES2790723T3 (enExample) |
| HU (1) | HUE048843T2 (enExample) |
| IL (1) | IL254943B (enExample) |
| MX (1) | MX379586B (enExample) |
| NZ (1) | NZ735783A (enExample) |
| SG (1) | SG11201708007VA (enExample) |
| WO (1) | WO2016185225A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ735783A (en) * | 2015-05-21 | 2021-12-24 | Pulmocide Ltd | Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof. |
| CN109329288A (zh) * | 2018-11-09 | 2019-02-15 | 青岛农业大学 | 伏立康唑在制备用于防治植物病原菌的杀菌剂中的应用 |
| US11977085B1 (en) | 2023-09-05 | 2024-05-07 | Elan Ehrlich | Date rape drug detection device and method of using same |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1292472C (en) | 1985-12-03 | 1991-11-26 | Alfonsus Guilielmus Knaeps | Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles |
| DE3852477T2 (de) * | 1987-11-20 | 1995-05-04 | Schering Corp | Tri- und tetrasubstituierte Oxetane und Tetrahydrofurane und deren Zwischenprodukte. |
| US5039676A (en) * | 1990-05-11 | 1991-08-13 | Schering Corporation | Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof |
| US5714490A (en) | 1993-12-21 | 1998-02-03 | Schering Corporation | Tetrahydrofuran antifungals |
| SK283035B6 (sk) * | 1993-12-21 | 2003-02-04 | Schering Corporation | Tetrahydrofuránová zlúčenina, spôsob jej prípravy, jej farmaceuticky prijateľný ester, soľ a farmaceutický prostriedok |
| US5486625A (en) | 1994-07-08 | 1996-01-23 | Schering Corporation | Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents |
| PL319635A1 (en) | 1995-06-02 | 1997-08-18 | Schering Corp | Tetrahydrofurane-based antimycotic agents |
| EP0957101A1 (en) * | 1998-05-14 | 1999-11-17 | Janssen Pharmaceutica N.V. | Water soluble azoles as broad-spectrum antifungals |
| AU2002257104B2 (en) * | 2001-04-03 | 2006-02-09 | Merck Sharp & Dohme Corp. | Antifungal composition with enhanced bioavailability |
| EP1870405A1 (en) * | 2006-06-22 | 2007-12-26 | Bioprojet | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
| CN101402613B (zh) * | 2008-11-14 | 2013-07-24 | 中国人民解放军第二军医大学 | 取代酚氧烷基胺三唑醇类抗真菌化合物及其制备方法 |
| CN102234267A (zh) * | 2010-04-21 | 2011-11-09 | 中国科学院上海药物研究所 | 新型三氮唑类抗真菌化合物、其药物组合物及其制备方法和用途 |
| WO2013036866A1 (en) * | 2011-09-07 | 2013-03-14 | The Johns Hopkins University | Itraconazole analogs and use thereof |
| DK3227277T3 (da) | 2014-12-05 | 2020-04-27 | Pulmocide Ltd | Antimykotisk forbindelse |
| NZ735783A (en) * | 2015-05-21 | 2021-12-24 | Pulmocide Ltd | Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof. |
-
2016
- 2016-05-20 NZ NZ735783A patent/NZ735783A/en unknown
- 2016-05-20 MX MX2017014814A patent/MX379586B/es unknown
- 2016-05-20 AU AU2016263669A patent/AU2016263669B2/en active Active
- 2016-05-20 ES ES16724958T patent/ES2790723T3/es active Active
- 2016-05-20 DK DK16724958.0T patent/DK3298006T3/da active
- 2016-05-20 EA EA201792558A patent/EA032454B1/ru not_active IP Right Cessation
- 2016-05-20 EP EP16724958.0A patent/EP3298006B1/en active Active
- 2016-05-20 SG SG11201708007VA patent/SG11201708007VA/en unknown
- 2016-05-20 HU HUE16724958A patent/HUE048843T2/hu unknown
- 2016-05-20 JP JP2017560525A patent/JP6811727B2/ja active Active
- 2016-05-20 KR KR1020177033395A patent/KR102653821B1/ko active Active
- 2016-05-20 CA CA2981945A patent/CA2981945C/en active Active
- 2016-05-20 CN CN201680028971.4A patent/CN107635988B/zh active Active
- 2016-05-20 WO PCT/GB2016/051467 patent/WO2016185225A1/en not_active Ceased
- 2016-11-09 US US15/347,402 patent/US9969720B2/en active Active
-
2017
- 2017-10-09 IL IL254943A patent/IL254943B/en active IP Right Grant
-
2018
- 2018-05-04 US US15/971,316 patent/US10280155B2/en active Active
-
2019
- 2019-03-20 US US16/359,349 patent/US10513511B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EA032454B1 (ru) | 2019-05-31 |
| HK1252779A1 (en) | 2019-05-31 |
| KR102653821B1 (ko) | 2024-04-02 |
| SG11201708007VA (en) | 2017-12-28 |
| US10513511B2 (en) | 2019-12-24 |
| WO2016185225A1 (en) | 2016-11-24 |
| DK3298006T3 (da) | 2020-03-30 |
| CA2981945C (en) | 2023-08-29 |
| MX379586B (es) | 2025-03-11 |
| AU2016263669A1 (en) | 2017-10-12 |
| MX2017014814A (es) | 2018-02-15 |
| CN107635988A (zh) | 2018-01-26 |
| US20170114047A1 (en) | 2017-04-27 |
| ES2790723T3 (es) | 2020-10-29 |
| IL254943B (en) | 2021-01-31 |
| KR20180010189A (ko) | 2018-01-30 |
| BR112017020807A2 (pt) | 2018-07-03 |
| JP2018520104A (ja) | 2018-07-26 |
| IL254943A0 (en) | 2017-12-31 |
| CN107635988B (zh) | 2021-06-18 |
| CA2981945A1 (en) | 2016-11-24 |
| EP3298006B1 (en) | 2020-01-01 |
| NZ735783A (en) | 2021-12-24 |
| AU2016263669B2 (en) | 2020-04-30 |
| US20190202813A1 (en) | 2019-07-04 |
| US20180251453A1 (en) | 2018-09-06 |
| US9969720B2 (en) | 2018-05-15 |
| JP6811727B2 (ja) | 2021-01-20 |
| EP3298006A1 (en) | 2018-03-28 |
| EA201792558A1 (ru) | 2018-05-31 |
| US10280155B2 (en) | 2019-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ719975A (en) | Active compound combinations comprising a (thio)carboxamide derivative and a fungicidal compound | |
| SI3999180T1 (sl) | Polimorfi(r)-n-(5-(5-etil-1,2,4-oksadiazol-3-il)-2,3-dihidro-1h-inden-1 -il)-1-metil-1h-pirazol-4-karboksamida | |
| IL287470A (en) | Compounds containing n-methyl-2-pyridone and pharmaceutically acceptable salts | |
| PL3619201T3 (pl) | 4-difluorometylobenzoilamidy o działaniu herbicydowym | |
| HUE047666T2 (hu) | Eljárás 2-[4-(4-Klórfenoxi)-2-(trifluormetil)fenil]-1-(1,2,4-triazol-1-il)-2-propanol elõállítására | |
| IL263004B (en) | A new crystalline form of n-[5-(5,3-difluoro-benzyl)-h1-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4 -ilamino)-benzamide | |
| EP3685701A4 (en) | PRESSURE RELIEF BACKPACK | |
| DK3395342T3 (da) | Tablet omfattende 1-(3-(2-(1-benzothiophen-5-YL)ethoxy)propyl)azetidin-3-ol eller salt deraf | |
| SG10202007913WA (en) | Formulations of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | |
| MX384034B (es) | Agente terapeutico para cancer de mama. | |
| ZA201708611B (en) | Pyrazole derivative, or pharmaceutically acceptable salt thereof | |
| PH12019501314A1 (en) | Pharmaceutical combination comprising a t-type calcium channel blocker | |
| IL254943B (en) | -(4-(4-(((3r,5r)-5-((1h-4,2,1-triazol-1-yl)methyl)-5-(4,2-difluorophenyl)tetrahydrofuran-3-yl (Methoxy)-3-methylphenyl)piperazin-1-yl)-n-(2-hydroxycyclohexyl)benzamide antifungal or a pharmaceutically acceptable salt thereof | |
| ZA201804843B (en) | Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl) acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide | |
| IL288575A (en) | N-(pyrid-3-yl)carboxamides fungicides | |
| IL243650A0 (en) | History of 1-(piperazine-1-yl)-2-([4,2,1]triazol-1-yl)-ethanone | |
| SG11201912281PA (en) | 2-[4-(methylaminomethyl)phenyl]-5-fluoro-benzofuran-7-carboxamide hydrochloride polymorph, preparation method therefor and application thereof | |
| PL3853219T3 (pl) | Herbicydowo działające podstawione fenylopirymidynohydrazydy | |
| IL265893A (en) | Crystal forms of 4-(2-((r1(2r,-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-n-methylpicolinamide | |
| HUE036361T2 (hu) | Herbicidszerûen hatásos 2-(helyettesített fenil)-ciklopentán-1,3-dion vegyületek és származékaik | |
| PL3153022T3 (pl) | N-(3’,4’-dichloro-5-metoksybifenyl-2-ylo)-3-(difluorometylo)-1-metylo-1H-pirazolo-4-karboksyamid | |
| PT3507287T (pt) | Antagonistas do recetor de p2x7 derivados de n-[2-(4- fenoxipiperidin-1-il)-2-(1,3-tiazol-5-il)etil]benzamida e n-[2-(4-benziloxipiperidin-1-il)-2-(1,3-tiazol-5- il)etil]benzamida substituídos | |
| HK40046188A (en) | Antifungal formulations for pulmonary administration comprising itraconazole | |
| HK40005184A (en) | Crystalline forms of 4-(2-((1r,2r)-2- hydroxycyclohexylamino) benzothiazol-6-yloxy)- n-methylpicolinamide | |
| IT201900000597U1 (it) | Tavola fermapiede per ponteggi. |